| Ytd | -65.94% | |
| 1y | -26.99% |
| Open | 5.85 | Prev Close | 5.79 | Low | 5.83 | High | 5.90 | Mkt Cap | 1.11B |
| Vol | 15.97K | Avg Vol | 3.56M | EPS | -1.06 | P/E | -5.46 | Forward P/E | -5.77 |
| Beta | -1.29 | Short Ratio | 5.97 | Inst. Own | 82.63% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-29 | 50-d Avg | 6.14 | 200-d Avg | 9.67 | 1yr Est | 21.94 |
WVE News
Genomics is reshaping healthcare, and these three stocks - MYGN, SANA and WVE - stand out as rapid a
CAMBRIDGE, Mass., July 07, 2026 (GLOBE NEWSWIRE) -- As previously announced, Wave Life Sciences Ltd.
The consensus price target hints at a 294.7% upside potential for Wave Life Sciences (WVE). While em
In Phase 1 portion of trial, WVE-007 improved body composition by inducing fat loss, including harmf
In Phase 1 portion of trial, WVE-007 improved body composition by inducing fat loss, including harmf
Wave Life Sciences (WVE) might move higher on growing optimism about its earnings prospects, which i
Wave Life Sciences Ltd. (WVE) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 202
CAMBRIDGE, Mass., June 01, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinica
This clinical-stage biotech develops precision genetic medicines for neurological and hepatic disord
SAN DIEGO, May 27, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating whether Wave Life
Wave Life Sciences Ltd. retains a Strong Buy rating, driven by near-term Accelerated Approval cataly
Wells Fargo analyst Benjamin Burnett maintains WAVE Life Sciences (NASDAQ:WVE) with a Overweight
The sponsorship helps expand proven strategies to consistently detect a genetic, irreversible, and p
HC Wainwright & Co. analyst Andrew S. Fein maintains WAVE Life Sciences (NASDAQ:WVE) with a B
Wave Life Sciences Ltd. (WVE) Shareholder/Analyst Call Transcript
Data reinforce WVE-006's potential to address both lung and liver manifestations of AATD with a
Data reinforce WVE-006's potential to address both lung and liver manifestations of AATD with a dura
CAMBRIDGE, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd.
Pre-Market Stock Futures: Futures are trading modestly higher as we hit the midweek mark, and some b
Wave Life Sciences (WVE) came out with a quarterly loss of $0.13 per share versus the Zacks Consensu
With recent FDA acceptance of the Phase 2a multidose portion of INLIGHT trial of WVE-007 (INHBE Gal
CAMBRIDGE, Mass., April 22, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinic
CAMBRIDGE, Mass., April 21, 2026 (GLOBE NEWSWIRE) -- As previously announced, Wave Life Sciences Ltd
CAMBRIDGE, Mass., April 15, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinic
Top Wall Street analysts have changed their outlook on top names. For full analyst rating changes, i
US stocks rise, Dow Jones gains 600+ pts. Apellis Pharma shares surge 136.4% after buyout by Biogen
Wave Life Sciences stock drops after INLIGHT Phase 1 data. WVE-007 shows fat reduction, lean mass st
Gainers Digital Media Solutions, Inc. (NYSE: DMS) jumped 78.8% to close at $2.11. Digital Media S
On Monday, 149 companies reached new 52-week lows.
Companies Reporting Before The Bell • CASI Pharmaceuticals (NASDAQ:CASI) is estimated to report